eFFECTOR Therapeutics announced the appointment of Kristen Harrington-Smith, Senior Vice President & Chief Commercial Officer at ImmunoGen, to the company's board of directors. Concurrent with Ms. Harrington-Smith's appointment, Jonathan Root, M.D., has resigned from the company's board of directors. Ms. Harrington-Smith has more than 20 years of pharmaceutical experience across oncology, rare diseases and primary care.

She currently serves as Senior Vice President & Chief Commercial Officer at ImmunoGen.